| Dr Shannon Patrick Calhoun, DO | |
|
2305 37th Ave Sw, Minot, ND 58701-7669 | |
| (701) 857-5000 | |
| Not Available |
| Full Name | Dr Shannon Patrick Calhoun |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 26 Years |
| Location | 2305 37th Ave Sw, Minot, North Dakota |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598715278 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cape Cod Healthcare | Hyannis, MA | Hospital |
| Mercy Hospital | Iowa city, IA | Hospital |
| Lovelace Medical Center | Albuquerque, NM | Hospital |
| Methodist Jennie Edmundson | Council bluffs, IA | Hospital |
| Baptist Beaumont Hospital | Beaumont, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcfarland Clinic Pc | 1254244239 | 320 |
| Leconte Radiology Pc | 1850373705 | 30 |
| Cheyenne Radiology Group | 1951293844 | 27 |
| Diagnostic Radiology Pc | 2264491570 | 42 |
| Radiologists Of Cape Cod Hospital | 2961872452 | 32 |
| Radiologic Medical Services Pc | 3577451491 | 27 |
| Allen Memorial Hospital Corporation | 4284546045 | 99 |
| Zia Diagnostic Imaging | 4284710369 | 31 |
| Central Kentucky Radiology Pllc | 8921906983 | 50 |
| Baptist Physician Network | 0547333890 | 75 |
| Chickasaw Nation Division Of Health | 8426957523 | 209 |
| Radiologists Of Cape Cod Hospital | 2961872452 | 32 |
| Reliant Medical Group Inc | 5597755322 | 543 |
| The Duluth Clinic Ltd | 2567374283 | 932 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Tulsa X-ray Laboratory Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144211582 PECOS PAC ID: 4183537426 Enrollment ID: O20031111000899 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Diagnostic Imaging Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427049956 PECOS PAC ID: 8820083645 Enrollment ID: O20040420000018 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Radadvantage A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376719666 PECOS PAC ID: 2163597899 Enrollment ID: O20081029000778 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Sacred Heart Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952535536 PECOS PAC ID: 6103729066 Enrollment ID: O20180613002122 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Leconte Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447210109 PECOS PAC ID: 1850373705 Enrollment ID: O20190129000306 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Radiology Associates Of Tallahassee Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003866773 PECOS PAC ID: 6709895675 Enrollment ID: O20190201000787 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Tallahassee Diag Imaging Ctr Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639129521 PECOS PAC ID: 9032193222 Enrollment ID: O20190222001138 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Memphis Physicians Radiological Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134231574 PECOS PAC ID: 9830123736 Enrollment ID: O20191008003698 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Kent Diagnostic Radiology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417044298 PECOS PAC ID: 3971591371 Enrollment ID: O20191011000247 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Mcfarland Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639135643 PECOS PAC ID: 1254244239 Enrollment ID: O20200220001225 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Lima Radiological Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497715361 PECOS PAC ID: 9931003977 Enrollment ID: O20200512001318 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Central Kentucky Radiology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952350761 PECOS PAC ID: 8921906983 Enrollment ID: O20200518000909 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Associated Radiologists Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215931290 PECOS PAC ID: 8123009941 Enrollment ID: O20210308001221 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Radiology Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215969407 PECOS PAC ID: 8325947799 Enrollment ID: O20210729001370 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Cheyenne Radiology Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023056082 PECOS PAC ID: 1951293844 Enrollment ID: O20220502001775 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Diagnostic Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497713291 PECOS PAC ID: 2264491570 Enrollment ID: O20220901003310 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Allen Memorial Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346292521 PECOS PAC ID: 4284546045 Enrollment ID: O20230316000540 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Radiologists Of Cape Cod Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073240586 PECOS PAC ID: 2961872452 Enrollment ID: O20230509001188 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Concord Radiology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598260515 PECOS PAC ID: 8628332061 Enrollment ID: O20230531002311 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Southeast Radiology Partners Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932799814 PECOS PAC ID: 2860886918 Enrollment ID: O20230601000665 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Zia Diagnostic Imaging |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558555003 PECOS PAC ID: 4284710369 Enrollment ID: O20231102002409 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Entity Name | Radiologic Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023061702 PECOS PAC ID: 3577451491 Enrollment ID: O20231206003681 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shannon Patrick Calhoun, DO 17310 Wright St Ste 103, Omaha, NE 68130-2405 Ph: (833) 228-6889 | Dr Shannon Patrick Calhoun, DO 2305 37th Ave Sw, Minot, ND 58701-7669 Ph: (701) 857-5000 |
News Archive
Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2.
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
KineMed, Inc. announced today a multi-year R&D collaboration with GlaxoSmithKline plc that will apply KineMed's proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Mayo Clinic has been recognized by the U.S. Business Leadership Network and the American Association of People With Disabilities for its efforts in its disability inclusion efforts. On a survey of Fortune 1,000 companies, Mayo Clinic was 1 of 42 companies that scored a perfect 100 on the Disability Equality Index. Mayo Clinic is featured on the 2016 DEI Best Places to Work list.
› Verified 3 days ago
Dr. Michael Grant, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 831 S Broadway, Suite 113, Minot, ND 58701 Phone: 701-857-3535 | |
James Allen Miller, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2305 37th Ave Sw, Minot, ND 58701 Phone: 701-857-5000 | |
Tyler M Neitlich, MD Radiology Medicare: May Accept Medicare Assignments Practice Location: 1 Burdick Expy W, Minot, ND 58701 Phone: 701-857-5000 | |
Dr. Danko Victor Vidovich, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Burdick Expy W, Minot, ND 58701 Phone: 701-857-5220 Fax: 701-857-5245 | |
Farzodd E Hanjani, MD Radiology Medicare: May Accept Medicare Assignments Practice Location: 2305 37th Ave Sw, Minot, ND 58701 Phone: 701-857-5000 | |
Mark W Whitman, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Burdick Expy W, Minot, ND 58701 Phone: 701-857-5220 Fax: 701-857-5245 | |
Barry Joseph Amos, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2305 37th Ave Sw, Minot, ND 58701 Phone: 701-857-5000 |